Home > News > Siemens Opens Research Facility for Molecular Imaging Biomarkers
February 15th, 2007
Siemens Opens Research Facility for Molecular Imaging Biomarkers
Siemens Medical Solutions has opened a new state-of-the-art research facility dedicated exclusively to the development of molecular imaging biomarkers, which will become in vivo diagnostic tools for identifying debilitating diseases such as cancer, and neurological diseases at their earliest stages.
The new Siemens' facility will be led by Hartmuth Kolb, Ph.D, vice president, Siemens Medical Solutions MI Biomarker Research. The facility will house scientists, dedicated to the discovery of new imaging agents and their clinical development, with the goal of bringing several new agents to the market over the next 5 - 10 years. Research and development efforts conducted at the facility will focus largely on oncology and neurology, and also include other areas such as inflammation and microfluidics/nanotechnology research.
Novel nanoparticle therapy promotes wound healing March 27th, 2015
Graphene reduces wear of alumina ceramic March 26th, 2015
Application of Graphene Oxide in Body Implants in Iran March 26th, 2015
Nanorobotic agents open the blood-brain barrier, offering hope for new brain treatments March 25th, 2015
Nanoscale worms provide new route to nano-necklace structures March 29th, 2015
Solving molybdenum disulfide's 'thin' problem: Research team increases material's light emission by twelve times March 29th, 2015
A first glimpse inside a macroscopic quantum state March 28th, 2015
DFG to Establish One Clinical Research Unit and Five Research Units: New Projects to Investigate Complications in Pregnancy, Particle Physics, Nanoparticles, Implants and Transport Planning / Approximately 13 Million Euros in Funding for an Initial Three-Year Period March 28th, 2015